ALLK
Price
$0.32
Change
-$0.00 (-0.00%)
Updated
Apr 3 closing price
Capitalization
28.87M
33 days until earnings call
ELAB
Price
$4.42
Change
-$0.13 (-2.86%)
Updated
Apr 3 closing price
Capitalization
2.63M
Ad is loading...

ALLK vs ELAB

Header iconALLK vs ELAB Comparison
Open Charts ALLK vs ELABBanner chart's image
Allakos
Price$0.32
Change-$0.00 (-0.00%)
Volume$2.97M
Capitalization28.87M
PMGC Holdings
Price$4.42
Change-$0.13 (-2.86%)
Volume$30.04K
Capitalization2.63M
ALLK vs ELAB Comparison Chart
Loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLK vs. ELAB commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLK is a Hold and ELAB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ALLK: $0.32 vs. ELAB: $4.42)
Brand notoriety: ALLK and ELAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLK: 134% vs. ELAB: 14%
Market capitalization -- ALLK: $28.87M vs. ELAB: $2.63M
ALLK [@Biotechnology] is valued at $28.87M. ELAB’s [@Biotechnology] market capitalization is $2.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLK’s FA Score shows that 1 FA rating(s) are green whileELAB’s FA Score has 1 green FA rating(s).

  • ALLK’s FA Score: 1 green, 4 red.
  • ELAB’s FA Score: 1 green, 4 red.
According to our system of comparison, ALLK is a better buy in the long-term than ELAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLK’s TA Score shows that 4 TA indicator(s) are bullish while ELAB’s TA Score has 5 bullish TA indicator(s).

  • ALLK’s TA Score: 4 bullish, 4 bearish.
  • ELAB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ELAB is a better buy in the short-term than ALLK.

Price Growth

ALLK (@Biotechnology) experienced а +36.34% price change this week, while ELAB (@Biotechnology) price change was -9.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

ALLK is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLK($28.9M) has a higher market cap than ELAB($2.63M). ELAB (-72.427) and ALLK (-73.554) have similar YTD gains . ELAB has higher annual earnings (EBITDA): -4.75M vs. ALLK (-111.04M). ALLK has more cash in the bank: 80.8M vs. ELAB (6.43M). ELAB has less debt than ALLK: ELAB (103K) vs ALLK (4.16M). ELAB has higher revenues than ALLK: ELAB (2.45M) vs ALLK (0).
ALLKELABALLK / ELAB
Capitalization28.9M2.63M1,101%
EBITDA-111.04M-4.75M2,339%
Gain YTD-73.554-72.427102%
P/E RatioN/AN/A-
Revenue02.45M-
Total Cash80.8M6.43M1,257%
Total Debt4.16M103K4,037%
FUNDAMENTALS RATINGS
ALLK: Fundamental Ratings
ALLK
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLKELAB
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
50%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
85%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TKC6.06-0.18
-2.88%
Turkcell Iletisim Hizmetleri AS
XGN4.27-0.16
-3.61%
Exagen
DMRC12.32-0.82
-6.24%
Digimarc Corp
TEL129.98-12.31
-8.65%
TE CONNECTIVITY Ltd
DGII25.15-2.60
-9.37%
Digi International

ALLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLK has been loosely correlated with VERU. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLK jumps, then VERU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLK
1D Price
Change %
ALLK100%
-0.40%
VERU - ALLK
46%
Loosely correlated
-8.41%
AXON - ALLK
38%
Loosely correlated
-3.35%
IMCR - ALLK
33%
Loosely correlated
-1.33%
AMRN - ALLK
32%
Poorly correlated
-2.18%
GANX - ALLK
31%
Poorly correlated
-5.29%
More

ELAB and

Correlation & Price change

A.I.dvisor tells us that ELAB and EPIX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAB and EPIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
-2.86%
EPIX - ELAB
31%
Poorly correlated
N/A
LXRX - ELAB
25%
Poorly correlated
-11.91%
EDSA - ELAB
22%
Poorly correlated
-5.31%
ALLK - ELAB
21%
Poorly correlated
-0.40%
REGN - ELAB
20%
Poorly correlated
-2.39%
More